Aris Water Solutions (NYSE:ARIS) Hits New 52-Week High at $17.95

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of "Buy" from Analysts



Shares of Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have received a consensus rating of “Buy” from the nine analysts that are presently covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 12-month target pric



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *